Australia markets closed

Imricor Medical Systems, Inc. (IMR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.5200+0.0100 (+1.96%)
At close: 03:48PM AEST
Full screen
Previous close0.5100
Open0.5150
Bid0.5000 x N/A
Ask0.5250 x N/A
Day's range0.5000 - 0.5200
52-week range0.4100 - 0.6550
Volume48,606
Avg. volume188,410
Market cap140.492M
Beta (5Y monthly)0.26
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris

    MINNEAPOLIS, June 25, 2024--Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter (VISABL-AFL) IDE clinical trial, commenced with two procedures performed at the Cardiovascular Institute of South Paris (ICPS) (https://icps.fr).